carvedilol has been researched along with American Trypanosomiasis in 5 studies
Excerpt | Relevance | Reference |
---|---|---|
"Chagas disease is still an important endemic disease in Brazil, and the cardiac involvement is its more severe manifestation." | 1.39 | Carvedilol enhances the antioxidant effect of vitamins E and C in chronic Chagas heart disease. ( Budni, P; Dalmarco, EM; Dalmarco, JB; Frode, TS; Pedrosa, RC; Wilhelm Filho, D, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Engel, JC | 1 |
Ang, KK | 1 |
Chen, S | 1 |
Arkin, MR | 1 |
McKerrow, JH | 1 |
Doyle, PS | 1 |
Horta, AL | 1 |
Figueiredo, VP | 1 |
Leite, ALJ | 1 |
Costa, GP | 1 |
Menezes, APJ | 1 |
Ramos, CO | 1 |
Pedrosa, TCF | 1 |
Bezerra, FS | 1 |
Vieira, PMA | 1 |
Talvani, A | 1 |
Budni, P | 1 |
Pedrosa, RC | 1 |
Dalmarco, EM | 1 |
Dalmarco, JB | 1 |
Frode, TS | 1 |
Wilhelm Filho, D | 1 |
Miranda, CP | 1 |
Botoni, FA | 1 |
Rocha, MO | 1 |
Heringer-Walther, S | 1 |
Moreira, Mda C | 1 |
Wessel, N | 1 |
Wang, Y | 1 |
Ventura, TM | 1 |
Schultheiss, HP | 1 |
Walther, T | 1 |
5 other studies available for carvedilol and American Trypanosomiasis
Article | Year |
---|---|
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Chagas Disease; Drug Evaluation, Preclinical; Hepatocy | 2010 |
The β-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Carvedilol; Catalase; Chagas Disease; Cytokines | 2018 |
Carvedilol enhances the antioxidant effect of vitamins E and C in chronic Chagas heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Antioxidants; Ascorbic Acid; Biomark | 2013 |
Immunopharmacological approach of carvedilol in chronic Chagas heart disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Carbazoles; Carvedilol; Chagas Disease; Humans; Propanolami | 2014 |
Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies?
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Carbazoles | 2006 |